( June 5, 2025, 2:05 PM EDT) -- WASHINGTON, D.C. — A Delaware federal judge rightly held that a COVID-19 vaccine from Moderna Inc. and related entities does not infringe on a biopharmaceutical company’s patents related to a type of lipid used in mRNA vaccines, a Federal Circuit U.S. Court of Appeals panel held June 4, saying the lipid in Moderna’s vaccine does not meet the limitations described in the pharmaceutical company’s patents....